Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00768599 · ClinicalTrials.gov registry record · Phase 2
A Study of Econazole Foam 1% in Athlete's Foot
A Phase 2 study of Tinea Pedis and Athlete's Foot, sponsored by AmDerma.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
- 6
- Study locations
NCT00768599: Completed Phase 2 study of Tinea Pedis and Athlete's Foot, sponsored by AmDerma.
NCT00768599 is a Phase 2 study of Tinea Pedis and Athlete's Foot that has completed, run by AmDerma. The registered enrollment target is 135 participants, below the 312-participant average among 9 other Tinea Pedis trials with a reported enrollment target (57% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00768599, a Phase 2 study of Tinea Pedis and Athlete's Foot, has completed, sponsored by AmDerma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1% -- is the same active pharmaceutical ingredient in a cream that your doctor can currently prescribe to treat athlete's foot. This study will help to understand if the foam works the same as the cream to treat athlete's foot.
Primary Outcome
A negative KOH and negative culture and no evidence of clinical disease as indicated by scores of 0 for each sign and symptom at Day 43.
Conditions Studied
Interventions
- DRUG Econazole Nitrate Cream 1%
- DRUG Econazole Nitrate Foam 1%
- DRUG Vehicle Foam
Study Locations (6)
California
- Stacy Smith, MD - San Diego
Michigan
- Daniel Stewart, DO - Clinton Township
Minnesota
- Steven Kempers, MD - Fridley
Tennessee
- Michael Gold, MD - Nashville
Texas
- Michael Jarratt, MD - Austin
Utah
- Leonard Swinyer, MD - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
What the finished NCT00768599 record still lists
NCT00768599 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 312-participant average among 9 other Tinea Pedis trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Tinea Pedis appearing as the primary indexed condition, and to 3 interventions - of which Econazole Nitrate Cream 1% is the first listed.
NCT00768599 lists 6 locations in 6 states (California, Michigan, Minnesota).
Frequently Asked Questions
What is clinical trial NCT00768599 about?
NCT00768599 is a clinical study titled "A Study of Econazole Foam 1% in Athlete's Foot". This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1% -- is the same active pharmaceutical ingredient in a cream that your doctor can currently prescrib...
What is the current status of trial NCT00768599?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2008-03. Estimated completion is 2008-10.
What conditions does trial NCT00768599 study?
This clinical trial studies the following conditions: Tinea Pedis, Athlete's Foot.
What interventions are being tested in trial NCT00768599?
The interventions under investigation include: Econazole Nitrate Cream 1% (DRUG), Econazole Nitrate Foam 1% (DRUG), Vehicle Foam (DRUG).
Who is sponsoring clinical trial NCT00768599?
This trial is sponsored by AmDerma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00768599 being conducted?
This trial has 6 study locations across California, Michigan, Minnesota, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tinea Pedis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00768599's enrollment target sits among peer trials
135 7th of 9 higher than 3 of 9 other Tinea Pedis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tinea Pedis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
RECRUITING · Phase 2
-
Three-Arm Trial of Novel Treatment for Tinea Pedis
COMPLETED · Phase 2
-
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
COMPLETED · Phase 1
-
Spread of Dermatophytes Among Families
COMPLETED
-
BE Study of Naftifine HCL
COMPLETED · Phase 3
-
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia